Junhemeng Biopharmaceutical

Junhemeng Biopharmaceutical

A recombinant protein drug developer.

Launch date
Employees
Market cap
-
Enterprise valuation
$110—165m (Dealroom.co estimates Sep 2024.)
小营街道 Zhejiang (HQ)
Authorizing premium user...